Noveome Biotherapeutics nabs $15 mln Series D
Pittsburgh-based Noveome Biotherapeutics Inc, a clinical-stage biopharmaceutical company, has secured $15 million in Series D financing. The company's investors included U.S. Department of Defense and the Commonwealth of Pennsylvania and Allegheny County.
9 April 2019•1 min read
